title: Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy.
abstract: The presence of metabolic syndrome in patients with hypertension significantly increases the risk of cardiovascular disease, type 2 diabetes and mortality. Our aim is to estimate the economic burden to the health service of metabolic syndrome (MetS) in patients with hypertension and its consequences, in three European countries in 2008, and to forecast future economic burden in 2020 using projected demographic estimates and assumptions around the growth of MetS. An age-, sex- and risk group-structured prevalence-based cost of illness model was developed using the United States Adult Treatment Panel III of the National Cholesterol Education Program criteria to define MetS. Data sources included published information and public use databases on disease prevalence, incidence of cardiovascular events, prevalence of type 2 diabetes, treatment patterns and cost of management in Germany, Spain and Italy. The economic burden to the health service of MetS in patients with hypertension has been estimated at 24,427 euro, 1,900 euro and 4,877 euro million in Germany, Spain and Italy, and is forecast to rise by 59, 179 and 157%, respectively, by 2020. The largest components of costs included the management of prevalent type 2 diabetes and incident cardiovascular events. Mean annual costs per hypertensive patient were around three-fold higher in subjects with MetS compared to those without and rose incrementally with the additional number of MetS components present. In conclusion, the presence of MetS in patients with hypertension significantly inflates economic burden, and costs are likely to increase in the future due to an aging population and an increase in the prevalence of components of MetS.
authors.affiliation: Fakultät für Volkswirtschaftslehre, L 7, 3-5, 2. OG, Raum 21, 68131, Mannheim, Germany. wille@uni-mannheim.de
authors.forename: Eberhard
authors.initials: E
authors.lastname: Wille
authors.forename: Jürgen
authors.initials: J
authors.lastname: Scholze
authors.forename: Eduardo
authors.initials: E
authors.lastname: Alegria
authors.forename: Claudio
authors.initials: C
authors.lastname: Ferri
authors.forename: Sue
authors.initials: S
authors.lastname: Langham
authors.forename: Warren
authors.initials: W
authors.lastname: Stevens
authors.forename: David
authors.initials: D
authors.lastname: Jeffries
authors.forename: Kerstin
authors.initials: K
authors.lastname: Uhl-Hochgraeber
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications / Q000191:economics / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000191:economics / Q000517:prevention & control; D005858:Germany / Q000453:epidemiology; D005102:Health Expenditures; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000191:economics* / Q000453:epidemiology; D007558:Italy / Q000453:epidemiology; D024821:Metabolic Syndrome / Q000150:complications* / Q000453:epidemiology; D018803:Models, Economic; D015995:Prevalence; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology
references.citation: Blood Press. 2007;16(6):347-53
references.pmid: 18058454
references.citation: Am J Med. 2006 Oct;119(10):812-9
references.pmid: 17000207
references.citation: Obes Res. 2004 Feb;12(2):173-9
references.pmid: 14981208
references.citation: J Hypertens. 2008 Sep;26(9):1801-8
references.pmid: 18698215
references.citation: J Hypertens. 2006 May;24(5):837-43
references.pmid: 16612244
references.citation: J Cardiometab Syndr. 2007 Winter;2(1):9-15
references.pmid: 17684454
references.citation: Eur Heart J. 2007 Jun;28(12):1462-536
references.pmid: 17562668
references.citation: Int J Clin Pract. 2005 Jun;59(6):632-8
references.pmid: 15924589
references.citation: J Hypertens. 2008 Oct;26(10):1891-900
references.pmid: 18806611
references.citation: Am J Cardiol. 2008 Aug 15;102(4):424-8
references.pmid: 18678299
references.citation: Am J Hypertens. 2006 Feb;19(2):189-96; discussion 197-8
references.pmid: 16448891
references.citation: Atherosclerosis. 2008 Mar;197(1):147-53
references.pmid: 17466306
references.citation: Curr Med Res Opin. 2007 Mar;23(3):495-503
references.pmid: 17355731
references.citation: Circulation. 2002 Dec 17;106(25):3143-421
references.pmid: 12485966
references.citation: Annu Rev Nurs Res. 2000;18:48-90
references.pmid: 10918932
references.citation: BMC Public Health. 2008 Jun 05;8:200
references.pmid: 18533989
references.citation: Am J Hypertens. 2007 May;20(5):558-64
references.pmid: 17485022
references.citation: Blood Press. 2009;18(6):308-47
references.pmid: 20001654
references.citation: JAMA. 2003 May 14;289(18):2363-9
references.pmid: 12746359
references.citation: J Hypertens. 2007 Jul;25(7):1491-8
references.pmid: 17563573
references.citation: Blood Press. 2007;16(1):20-7
references.pmid: 17453748
references.citation: J Hum Hypertens. 2007 Oct;21(10):795-801
references.pmid: 17508012
references.citation: Lancet. 2007 Jan 20;369(9557):201-7
references.pmid: 17240286
references.citation: Med Clin (Barc). 2006 Mar 25;126(11):406-9
references.pmid: 16595083
references.citation: J Hypertens. 1998 Aug;16(8):1103-12
references.pmid: 9794712
references.citation: Diabetes Care. 2005 Jul;28(7):1769-78
references.pmid: 15983333
references.citation: Metab Syndr Relat Disord. 2009 Aug;7(4):305-14
references.pmid: 19558267
references.citation: J Am Coll Cardiol. 2007 Jan 30;49(4):403-14
references.pmid: 17258085
references.citation: CMAJ. 1999 Jan 12;160(1):31-7
references.pmid: 9934341
references.citation: Health Policy. 2007 Oct;83(2-3):257-67
references.pmid: 17335933
references.citation: Diabetologia. 2002 Jul;45(7):S5-12
references.pmid: 12136405
references.citation: Rev Esp Cardiol. 2008 Oct;61(10):1030-40
references.pmid: 18817679
references.citation: Stroke. 1998 Jan;29(1):244-50
references.pmid: 9445358
references.citation: Diabetes Care. 2005 Sep;28(9):2289-304
references.pmid: 16123508
references.citation: Circulation. 2004 Nov 2;110(18):2968-75
references.pmid: 15520336
references.citation: Diabetes Care. 2001 Apr;24(4):683-9
references.pmid: 11315831
references.citation: Pharmacoeconomics. 2004;22(15):1001-14
references.pmid: 15449964
references.citation: J Hum Hypertens. 1992 Dec;6(6):481-3
references.pmid: 1296013
references.citation: Blood Press. 2004;13(2):80-8
references.pmid: 15182110
references.citation: Int J Clin Pharmacol Ther. 2010 Mar;48(3):173-83
references.pmid: 20197011
references.citation: J Hypertens. 2004 Jan;22(1):51-7
references.pmid: 15106794
references.citation: J Hypertens. 2008 Apr;26(4):819-24
references.pmid: 18327094
references.citation: J Hypertens. 2005 Nov;23(11):2093-100
references.pmid: 16208153
references.citation: Ann Rheum Dis. 2004 Apr;63(4):395-401
references.pmid: 15020333
references.citation: Hypertension. 2007 Jan;49(1):40-7
references.pmid: 17130308
references.citation: Blood Press. 2002;11(1):35-45
references.pmid: 11926349
references.citation: Am J Hypertens. 2007 Dec;20(12):1291-6
references.pmid: 18047919
references.citation: Diabetes Care. 2007 Oct;30(10):2553-8
references.pmid: 17623825
references.citation: Stroke. 2009 Jan;40(1):200-5
references.pmid: 18927451
references.citation: J Hypertens. 2001 Jan;19(1):149-55
references.pmid: 11204296
references.citation: Am J Med. 2006 May;119(5 Suppl 1):S24-30
references.pmid: 16563944
references.citation: Curr Med Res Opin. 2008 Jan;24(1):121-7
references.pmid: 18031596
references.citation: J Clin Hypertens (Greenwich). 2007 Aug;9(8):595-600
references.pmid: 17673880
references.citation: J Hypertens. 2008 Oct;26(10):2064-70
references.pmid: 18806632
references.citation: J Clin Hypertens (Greenwich). 2004 Feb;6(2):76-84
references.pmid: 14872145
references.citation: J Am Coll Cardiol. 2004 May 19;43(10):1817-22
references.pmid: 15145106
references.citation: Circulation. 2003 Jul 29;108(4):414-9
references.pmid: 12860911
references.citation: J Hum Hypertens. 2007 May;21(5):366-73
references.pmid: 17301825